Professor Perry J. Pickhardt calls for more targeted screening of colorectal cancer at the BIR/Canon Mayneord Memorial Lecture

16 July 2018

Perry - Canon LogoProfessor Perry J Pickhardt delivered the eponymous Mayneord Memorial Lecture titled “The natural history of colorectal neoplasia?” on Monday 2 July to an audience of radiologists, radiographers, scientists and oncologists gathered at UKRCO in Liverpool.

In his engaging talk, Professor Pickhardt said colorectal cancer is the second leading cause of cancer death in both men and women.  This is a preventable disease and even early cancers are effectively treatable. In many parts of the developed world it is either under-screened or not screened at all, whilst in parts of the USA arguably too many colonoscopies are performed, which reveal many tiny polyps, very few of which will ever turn into cancer. He went on to describe the optimum screening process using CT colonography and then outlined the polyp to cancer sequence, CT colonography overview, and covered both static and dynamic predictors. He finished with a positive message that a prolonged window exists for colorectal cancer prevention and early detection and that CT colonography is highly attractive for population screening.

Professor Pickhardt has a worldwide reputation as a clinician, academic, and educator in GI imaging. He is currently Chief of Gastrointestinal Imaging at the University Of Wisconsin School Of Medicine and Public Health, and the Medical Director of Cancer Imaging at the centre. Originally graduating in physics, he had a career in the US Navy as a radiologist, including a period at Guantanamo Bay, Cuba.

BIR President Andy Rogers said “Professor Pickhardt’s talk was a tour-de-force of the current evidence surrounding the diagnosis of colon cancer and the important role of CT Colonography (CTC) in that diagnosis. It was a pleasure to welcome Perry to UKRCO and I wish him every success in forwarding the cause of colon cancer screening by CTC.”

After the lecture, Professor Pickhardt was presented with a commemorative trophy. He said, "I was truly honoured to receive the BIR/Canon Mayneord Award and be given the opportunity to deliver a lecture at UKRCO in Liverpool.”

Mark Hitchman, Managing Director Canon Medical, who presented the award, said, ”It is crucial that we, as society, take note and act on the extensive knowledge and experience of people like Professor Perry Pickhardt, because early intervention with diseases like colon cancer means outcomes are so much better for patients, and affordable for healthcare systems that are increasingly over stretched.”

The BIR Canon Medical Systems Mayneord Memorial Lecture is an annual award made to an individual or a group of collaborators in recognition of recent or current contributions in the wide and expanding field of radiology. The lecture was founded in 1984 in memory of Professor Val Mayneord CBE FRS, past president of the BIR. The lecture is given at the annual UKRCO.

The award recognises values, skills and contributions at the forefront of medical imaging, in line with its sponsor, Canon Medical Systems’ commitment to education.

The lecture can be viewed on the UKRCO website here https://ukrco.org.uk/webcasts/

Previous recipients include Professor Keith McNeill (2017), Professor Adrian Dixon (2016) Professor Sir Muir Gray (2015), Professor John Buscombe (2014), Professor Richard Ehman (2012), Professor Sir Mike Richards (2011) and Lord Darzi (2010).

Ends

Photograph: (left to right) Andy Rogers (BIR President), Professor Perry J Pickhardt and Mark Hitchman (Managing Director, Canon Medical).

 DOWNLOAND PRESS RELEASE

Notes to Editors

About Professor Mayneord

Professor William Valentine Mayneord entered the field of medical physics in 1924 at St Bart's Hospital in London then to the Cancer Hospital, now the Royal Marsden Hospital. During WWII he was seconded by the government to work in Canada on the radiological aspects of atomic energy development.

He is recognised as the leading authority in the UK on the applications of radiation dosimetry to medical radiology and the problems of radiation hazards. He was awarded a CBE in 1965.

 

About The British Institute of Radiology

  • The British Institute of Radiology is an independent multidisciplinary organisation, and a registered charity, whose membership is open to everyone with an interest in radiology and radiation oncology.
  • The British Institute of Radiology (BIR) is the oldest radiological society in the world.
  • We strive to ensure that the potential of image science and radiation technology to prevent, detect and combat disease is fully realised. We believe in the importance of research and education, and we promote collaboration and the sharing of knowledge and understanding.
  • To help fulfil our aims, we undertake a wide range of activities, including publishing, the organisation of scientific meetings and conferences and the provision of library and information services.

Registered Charity No: 215869

 

About Canon Medical Systems

https://uk.medical.canon

Canon Medical Systems Corporation develops and manufactures diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems and provides them to around 140 countries and regions around the world, offering technology that provides faster diagnosis and early treatment. Under the slogan "Made for Life" (Made for Partnerships, Made for Patients, Made for You.), Canon Medical Systems is making positive contributions toward hospital management, and provides a range of patient-friendly healthcare systems and services.

 

For information about this release please contact:

Carole Cross, Communications Manager, 48-50 St John Street, London EC1M 4DG

Tel. 020 3668 2224    carole.cross@bir.org.uk  www.bir.org.uk

British Institute of Radiology - Cookie Disclaimer

The British Institute of Radiology website uses cookies to provide you with essential online features. If you continue to use our site without changing your browser settings, we'll assume you are happy to receive cookies. Please read our Cookie policy for more information.